BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karbalai Saleh S, Oraii A, Soleimani A, Hadadi A, Shajari Z, Montazeri M, Moradi H, Talebpour M, Sadat Naseri A, Balali P, Akhbari M, Ashraf H. The association between cardiac injury and outcomes in hospitalized patients with COVID-19.Intern Emerg Med. 2020;15:1415-1424. [PMID: 32772283 DOI: 10.1007/s11739-020-02466-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zwaenepoel B, Dhont S, Schaubroeck H, Gevaert S. The use of cardiac troponins and B-type natriuretic peptide in COVID-19. Acta Cardiol 2021;:1-6. [PMID: 34459705 DOI: 10.1080/00015385.2021.1970403] [Reference Citation Analysis]
2 Anzola GP, Bartolaminelli C, Gregorini GA, Coazzoli C, Gatti F, Mora A, Charalampakis D, Palmigiano A, De Simone M, Comini A, Dellaglio E, Cassetti S, Chiesa M, Spedini F, d'Ottavi P, Savio MC. Neither ACEIs nor ARBs are associated with respiratory distress or mortality in COVID-19 results of a prospective study on a hospital-based cohort. Intern Emerg Med 2020;15:1477-84. [PMID: 32965603 DOI: 10.1007/s11739-020-02500-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Prasitlumkum N, Chokesuwattanaskul R, Thongprayoon C, Bathini T, Vallabhajosyula S, Cheungpasitporn W. Incidence of Myocardial Injury in COVID-19-Infected Patients: A Systematic Review and Meta-Analysis. Diseases 2020;8:E40. [PMID: 33120956 DOI: 10.3390/diseases8040040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
4 Colombo C, Garatti L, Ferrante G, Casadei F, Montalto C, Crimi G, Cogliati C, Ammirati E, Savonitto S, Morici N. Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people. J Geriatr Cardiol 2021;18:534-48. [PMID: 34404990 DOI: 10.11909/j.issn.1671-5411.2021.07.001] [Reference Citation Analysis]
5 Pazoki M, Chichagi F, Hadadi A, Kafan S, Montazeri M, Kazemian S, Aminorroaya A, Ebrahimi M, Ashraf H, Hazaveh MM, Khajavi MR, Moharari RS, Sharifnia SH, Saleh SK, Rahimzadeh H, Goodarzi N, Heydarian P. Association of clinical characteristics, antidiabetic and cardiovascular agents with diabetes mellitus and COVID-19: a 7-month follow-up cohort study. J Diabetes Metab Disord 2021;:1-11. [PMID: 34778117 DOI: 10.1007/s40200-021-00901-4] [Reference Citation Analysis]
6 Zeng L, Wang S, Cai J, Sun S, Wang S, Li J, Sun L. Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis. Epidemiol Infect 2020;148:e266. [PMID: 33092664 DOI: 10.1017/S0950268820002587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev 2021;34:e00133-20. [PMID: 33441314 DOI: 10.1128/CMR.00133-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
8 Kwok M, Lee C, Li HS, Deng R, Tsoi C, Ding Q, Tsang SY, Leung KT, Yan BP, Poon EN. Remdesivir induces persistent mitochondrial and structural damage in human induced pluripotent stem cell derived cardiomyocytes. Cardiovasc Res 2021:cvab311. [PMID: 34609482 DOI: 10.1093/cvr/cvab311] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shah SMI, Bin Zafar MD, Yasmin F, Ghazi EM, Jatoi HN, Jawed A, Nadeem A, Khan Z, Anas Z, Siddiqui SA. Exploring the impact of the COVID-19 pandemic on cardiac surgical services: A scoping review. J Card Surg 2021;36:3354-63. [PMID: 34137067 DOI: 10.1111/jocs.15746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ashraf H, Soleimani A, Kazemi saeid A, Sadat Naseri A, Majidi F, Peirovi N, Karbalai Saleh S. Troponin I biomarker as a strong prognostic factor for predicting COVID-19 mortality: A systematic review. World J Meta-Anal 2021; 9(4): 342-352 [DOI: 10.13105/wjma.v9.i4.342] [Reference Citation Analysis]
11 De Carvalho H, Leonard-Pons L, Segard J, Goffinet N, Javaudin F, Martinage A, Cattin G, Tiberghien S, Therasse D, Trotignon M, Arabucki F, Ribes S, Le Bastard Q, Montassier E. Electrocardiographic abnormalities in COVID-19 patients visiting the emergency department: a multicenter retrospective study. BMC Emerg Med 2021;21:141. [PMID: 34798827 DOI: 10.1186/s12873-021-00539-8] [Reference Citation Analysis]
12 Sinclair JE, Zhu Y, Xu G, Ma W, Shi H, Ma KL, Cao CF, Kong LX, Wan KQ, Liao J, Wang HQ, Arentz M, Redd MA, Gallo LA, Short KR. A meta-analysis on the role of pre-existing chronic disease in the cardiac complications of SARS-CoV-2 infection. iScience 2021;24:102264. [PMID: 33688629 DOI: 10.1016/j.isci.2021.102264] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Mizera L, Borst O. COVID-19 and the Incidence of Acute Myocardial Injury. Hamostaseologie 2021;41:356-64. [PMID: 34695852 DOI: 10.1055/a-1554-6416] [Reference Citation Analysis]
14 Cipriani A, Capone F, Donato F, Molinari L, Ceccato D, Saller A, Previato L, Pesavento R, Sarais C, Fioretto P, Iliceto S, Gregori D, Avogaro A, Vettor R. Cardiac injury and mortality in patients with Coronavirus disease 2019 (COVID-19): insights from a mediation analysis. Intern Emerg Med 2021;16:419-27. [PMID: 32984929 DOI: 10.1007/s11739-020-02495-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
15 Soleimani A, Kazemian S, Karbalai Saleh S, Aminorroaya A, Shajari Z, Hadadi A, Talebpour M, Sadeghian H, Payandemehr P, Sotoodehnia M, Bahreini M, Najmeddin F, Heidarzadeh A, Zivari E, Ashraf H. Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19. Am J Hypertens 2020;33:1102-11. [PMID: 32920644 DOI: 10.1093/ajh/hpaa149] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
16 Brown WA, Moore EM, Watters DA. Mortality of patients with COVID ‐19 who undergo an elective or emergency surgical procedure: a systematic review and meta‐analysis. ANZ Journal of Surgery 2021;91:33-41. [DOI: 10.1111/ans.16500] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Gorecka M, McCann GP, Berry C, Ferreira VM, Moon JC, Miller CA, Chiribiri A, Prasad S, Dweck MR, Bucciarelli-Ducci C, Dawson D, Fontana M, Macfarlane PW, McConnachie A, Neubauer S, Greenwood JP; COVID-HEART investigators. Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART-a UK, multicentre, observational study. J Cardiovasc Magn Reson 2021;23:77. [PMID: 34112195 DOI: 10.1186/s12968-021-00752-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Arcari L, Luciani M, Cacciotti L, Musumeci MB, Spuntarelli V, Pistella E, Martolini D, Manzo D, Pucci M, Marone C, Melandri S, Ansalone G, Santini C, Martelletti P, Volpe M, De Biase L. Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients. Intern Emerg Med 2020;15:1467-76. [DOI: 10.1007/s11739-020-02498-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
19 Kim CW, Aronow WS. COVID-19, cardiovascular diseases and cardiac troponins. Future Cardiol 2021. [PMID: 34476978 DOI: 10.2217/fca-2021-0054] [Reference Citation Analysis]
20 Zhao BC, Liu WF, Lei SH, Zhou BW, Yang X, Huang TY, Deng QW, Xu M, Li C, Liu KX. Prevalence and prognostic value of elevated troponins in patients hospitalised for coronavirus disease 2019: a systematic review and meta-analysis. J Intensive Care 2020;8:88. [PMID: 33292649 DOI: 10.1186/s40560-020-00508-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
21 Abate SM, Mantefardo B, Nega S, Chekole YA, Basu B, Ali SA, Taddesse M. Global burden of acute myocardial injury associated with COVID-19: A systematic review, meta-analysis, and meta-regression. Ann Med Surg (Lond) 2021;68:102594. [PMID: 34336202 DOI: 10.1016/j.amsu.2021.102594] [Reference Citation Analysis]
22 Ogungbe O, Kumbe B, Fadodun O, Latha T, Meyer D, Asala A, Davidson PM, Dennison Himmelfarb CR, Post WS, Commodore-Mensah Y. Subclinical myocardial injury, coagulopathy, and inflammation in COVID-19: A meta-analysis of 41,013 hospitalized patients. Int J Cardiol Heart Vasc 2022;:100950. [PMID: 35005211 DOI: 10.1016/j.ijcha.2021.100950] [Reference Citation Analysis]